Processa Pharmaceuticals Inc (PCSA) Stock Price, Quote & News

Company Profile

Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment. Its drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms of killing the cancer cells. The company's pipeline includes three chemotherapy drugs comprising Gemcitabine, PCS3117 that has completed Phase 2a clinical t...

Industry: Biotechnology

Sector: Healthcare

Phone: 443 776 3133

Fax: 443 288 4420

Website: www.processapharmaceuticals.com

Address:

7380 Coca Cola Drive, Suite 106, Hanover, United States

NLEBRON3 Jul. 28 at 5:08 PM

$PCSA

0 · Reply

Stockeye2 Jul. 28 at 4:53 PM

$PCSA

1 · Reply

TheDrunkTrader69 Jul. 28 at 4:04 PM

$PCSA Watch the institutional owners here just saying, i see more and more buyers on the board this week.

1 · Reply

Paraplego Jul. 28 at 3:54 PM

$PCSA Lets be Real for RS Investor meeting is needed so yeah there will be no RS adding more stocks is just part of plan with upcoming catalysts on the way and partnerships so yeah keep spreading lies how PCSA is going to 0 i cant see that comming with 450 mil usd deal that is ongoing.... same 5 people saying every day how PCSA is dead for weeks now question is who is paying you to keep saying how stock is bad and yet you are still here why sell and move on right ?

1 · Reply

upupup16 Jul. 28 at 3:45 PM

$PCSA when RS ?

0 · Reply

Schizoo Jul. 28 at 2:40 PM

$PCSA in for another swing..

0 · Reply

upupup16 Jul. 28 at 2:37 PM

$PCSA this pos will never squeeze… more likely to rs sooner than later

0 · Reply

race2zero Jul. 28 at 2:35 PM

$PCSA what the hell, why not pick up 5k more.

0 · Reply

brallt Jul. 28 at 2:05 PM

$PCSA Today us a shake out day,retraction, retracement, cool off. from the recent nice up trend. Whatever word you wish to use. But i will be giving it a bit more time to "shake out" before I start to accumulate more. These are the type of days you look to add on if accumulating a swing.

0 · Reply

TheDrunkTrader69 Jul. 28 at 1:50 PM

$PCSA Idk, not advise do your own due diligence but think something big coming 🤔

1 · Reply

Processa Pharmaceuticals Provides Portfolio and Business Update

Jun 17, 2025, 12:26 PM EDT - 5 weeks ago

Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering

Jun 17, 2025, 9:00 AM EDT - 5 weeks ago

Processa Pharmaceuticals Signs Binding Term Sheet Granting Intact Therapeutics Exclusive Option to License Phase 2 Gastroparesis Drug Candidate

Jun 13, 2025, 8:00 AM EDT - 6 weeks ago

Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025

May 30, 2025, 9:00 AM EDT - 2 months ago

Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting

Apr 15, 2025, 8:00 AM EDT - 3 months ago

Processa Pharmaceuticals' Dr. David Young to Present at World Orphan Drug Congress USA 2025

Mar 18, 2025, 8:30 AM EDT - 4 months ago

Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference

Feb 7, 2025, 8:00 AM EST - 6 months ago

Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference

Jan 30, 2025, 5:17 PM EST - 6 months ago

Processa Pharmaceuticals Announces Closing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Jan 27, 2025, 8:30 PM EST - 6 months ago

Processa Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Oct 2, 2024, 4:05 PM EDT - 10 months ago

Processa Pharmaceuticals Announces First Patient Dosed in Phase 2 Clinical Trial of NGC-Cap in Metastatic Breast Cancer

Sep 3, 2024, 8:00 AM EDT - 11 months ago

Processa Pharmaceuticals to Participate in Investor and Industry Conferences During September

Jun 11, 2024, 8:20 AM EDT - 1 year ago

Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b Dose-escalating Trial with NGC-Cap in Gastrointestinal Cancer

May 6, 2024, 8:00 AM EDT - 1 year ago

Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference

Apr 30, 2024, 8:00 AM EDT - 1 year ago

Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical Research

Mar 25, 2024, 8:15 AM EDT - 1 year ago

Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting

Feb 21, 2024, 8:15 AM EST - 1 year ago

Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference

Feb 14, 2024, 1:00 PM EST - 1 year ago

Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Conference

Feb 6, 2024, 8:30 AM EST - 1 year ago

Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

Feb 1, 2024, 4:22 PM EST - 1 year ago

Processa Pharmaceuticals Announces Closing of $7.0 Million Public Offering

Jan 26, 2024, 9:04 AM EST - 1 year ago

Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering

Jan 25, 2024, 11:29 AM EST - 1 year ago

What made Processa Pharmaceuticals stock nearly triple on Thursday?

Jan 25, 2024, 8:30 AM EST - 1 year ago

Processa Pharmaceuticals Announces Successful Completion of Phase 1b Safety Evaluation of NGC-Cap in Patients with Advanced Cancer Resulting in Recommended Phase 2 Doses

Jan 19, 2024, 7:45 AM EST - 1 year ago

Processa Pharmaceuticals Announces Expansion of NGC-Cap Program into Advanced or Metastatic Breast Cancer

Jan 18, 2024, 7:45 AM EST - 1 year ago

Processa Pharmaceuticals to Effect a 1-for-20 Reverse Stock Split

Jan 2, 2024, 5:06 PM EST - 1 year ago

Processa Pharmaceuticals to Present at the Biotech Showcase 2024

Dec 19, 2023, 9:00 AM EST - 1 year ago

Processa Pharmaceuticals Provides Interim Analysis from Ongoing Phase 1b Trial of Next Generation Capecitabine Showing Improved Safety Over Capecitabine

Dec 13, 2023, 9:00 AM EST - 1 year ago

Processa Pharmaceuticals Announces Successful Phase 2 Meeting with FDA for Next Generation Capecitabine

Nov 30, 2023, 8:15 AM EST - 1 year ago

Processa Pharmaceuticals to Present at the MedInvest Oncology Investor Conference

Nov 29, 2023, 8:15 AM EST - 1 year ago

Processa Pharmaceuticals Issues Letter to Shareholders Highlighting Corporate Strategy, Drug Pipeline, and Outlook

Nov 13, 2023, 1:40 PM EST - 1 year ago

Processa Pharmaceuticals, Inc. Mourns the Sudden Passing of Board Member Virgil Thompson

Nov 9, 2023, 8:15 AM EST - 1 year ago

Processa Pharmaceuticals to Present at the 20th Orphan Drugs and Rare Diseases Global Congress 2023 Americas

Nov 1, 2023, 8:15 AM EDT - 1 year ago

Processa Pharmaceuticals Announces Formation of Oncology Advisory Board with Renowned Key Opinion Leaders

Oct 13, 2023, 1:08 PM EDT - 1 year ago

Processa Pharmaceuticals to Present at the ThinkEquity Conference

Sep 6, 2023, 8:15 AM EDT - 2 years ago

Processa Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Aug 17, 2023, 8:05 AM EDT - 2 years ago

Processa Pharmaceuticals Provides Data Update Supporting a Potential Personalized Treatment Approach for Improved Cancer Care

Aug 10, 2023, 4:15 PM EDT - 2 years ago

Processa Pharmaceuticals to Present at the Sidoti & Co. Micro Cap Virtual Conference

Aug 8, 2023, 8:15 AM EDT - 2 years ago

Processa Pharmaceuticals Appoints Life Sciences Industry Veteran George Ng as Chief Executive Officer

Jun 14, 2023, 4:15 PM EDT - 2 years ago

Next Generation Chemotherapy: Improved Treatment for More Patients

May 22, 2023, 8:05 AM EDT - 2 years ago

Processa Pharmaceuticals to Participate in a Panel on Interaction with the FDA at the World Orphan Drug Congress

May 18, 2023, 8:00 AM EDT - 2 years ago

Processa Pharmaceuticals to Conduct Next Generation Chemotherapy-Capecitabine Phase 2 Trial Based on FDA Guidance and Project Optimus Oncology Initiative

Apr 28, 2023, 8:15 AM EDT - 2 years ago

Processa Pharmaceuticals to Present PCS12852 Gastroparesis Results at the Digestive Disease Week 2023 Annual Meeting

Mar 31, 2023, 4:14 PM EDT - 2 years ago

Processa Pharmaceuticals, Inc. (PCSA) Q4 2022 Earnings Call Transcript

Mar 30, 2023, 4:01 PM EDT - 2 years ago

Processa Pharmaceuticals Provides Corporate Update and Announces Year End 2022 Financial Results

Mar 23, 2023, 8:30 AM EDT - 2 years ago

Processa Pharmaceuticals to Host Conference Call to Discuss 2022 Year End Results and Provide Drug Development Update on March 30, 2023 at 4:30 p.m. EST

Mar 17, 2023, 8:30 AM EDT - 2 years ago

Processa Pharmaceuticals Announces First Patient Dosed in the 300 mg Dose Group with Next Generation Chemotherapy-Capecitabine

Mar 7, 2023, 8:30 AM EST - 2 years ago

Processa Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference

Feb 21, 2023, 8:30 AM EST - 2 years ago

Processa Pharmaceuticals Announces Prioritization on Development of Next Generation Chemotherapies

Feb 15, 2023, 8:30 AM EST - 2 years ago

Processa Pharmaceuticals, Inc. Announces Closing of $6.25 Million Registered Direct Offering, Which Included Retail Investors and Insiders, Priced at the Market Under Nasdaq Rules

Feb 10, 2023, 8:00 AM EST - 2 years ago

Processa Pharmaceuticals, Inc. Announces $6.25 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

NLEBRON3 Jul. 28 at 5:08 PM

$PCSA

0 · Reply

Stockeye2 Jul. 28 at 4:53 PM

$PCSA

1 · Reply

TheDrunkTrader69 Jul. 28 at 4:04 PM

$PCSA Watch the institutional owners here just saying, i see more and more buyers on the board this week.

1 · Reply

Paraplego Jul. 28 at 3:54 PM

1 · Reply

upupup16 Jul. 28 at 3:45 PM

$PCSA when RS ?

0 · Reply

Schizoo Jul. 28 at 2:40 PM

$PCSA in for another swing..

0 · Reply

upupup16 Jul. 28 at 2:37 PM

$PCSA this pos will never squeeze… more likely to rs sooner than later

0 · Reply

race2zero Jul. 28 at 2:35 PM

$PCSA what the hell, why not pick up 5k more.

0 · Reply

brallt Jul. 28 at 2:05 PM

0 · Reply

TheDrunkTrader69 Jul. 28 at 1:50 PM

$PCSA Idk, not advise do your own due diligence but think something big coming 🤔

1 · Reply

upupup16 Jul. 28 at 1:41 PM

$PCSA next PR will be an RS

0 · Reply

Paraplego Jul. 28 at 1:06 PM

$PCSA this information about selling 5 mil usd in shares might be incomplete they had option loan since they have money on the way why would they just pop more shares that makes no sense ?

1 · Reply

Jwa68 Jul. 28 at 12:52 PM

$PCSA

0 · Reply

jaechun Jul. 28 at 11:55 AM

$PCSA

0 · Reply

TheDrunkTrader69 Jul. 28 at 11:39 AM

$PCSA

0 · Reply

Jwa68 Jul. 28 at 9:14 AM

$PCSA https://www.tipranks.com/news/company-announcements/processa-pharmaceuticals-files-prospectus-for-stock-sale#google_vignette

0 · Reply

ibaian Jul. 28 at 5:20 AM

$PCSA

0 · Reply

ibaian Jul. 28 at 5:16 AM

$PCSA

0 · Reply

Coaa Jul. 28 at 12:11 AM

$PCSA 0.2350 -> 0.2658 whats up with that 🧐

0 · Reply

Jwa68 Jul. 26 at 11:22 PM

$PCSA Processa Pharmaceuticals Files Prospectus for Stock Sale https://www.tipranks.com/news/company-announcements/processa-pharmaceuticals-files-prospectus-for-stock-sale#google_vignette

0 · Reply

Jwa68 Jul. 26 at 11:13 PM

$PCSA Definitely like playing the lottery and similar odds. Odds in any lottery are about one in 300 million. That's about 1 in 292.2 million for Powerball and 1 in 302.6 million for Mega Millions.

1 · Reply

MGeronimo Jul. 26 at 10:42 PM

$PCSA In AT .23 5 x normal as a long term LOTTERY PLAY

0 · Reply

Market Cap	2.89M
Revenue (ttm)	0.00
Net Income (ttm)	-11.85M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	3,065,488
Avg Vol	22,381,049
Day's Range	N/A - N/A
Shares Out	11.88M
Stochastic %K	62%
Beta	1.30
Analysts	Sell
Price Target	$2.00